Gene Therapy - Short Notes (10 Marks)

ls -la /tmp/workspace/ 2>/dev/null || mkdir -p /tmp/workspace && echo "created"

mkdir -p /tmp/workspace/gene-therapy && python3 << 'EOF' from reportlab.lib.pagesizes import A4 from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.lib.units import cm from reportlab.lib import colors from reportlab.platypus import (SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable, KeepTogether) from reportlab.lib.enums import TA_CENTER, TA_LEFT, TA_JUSTIFY output_path = "/tmp/workspace/gene-therapy/Gene_Therapy_Short_Notes.pdf" doc = SimpleDocTemplate( output_path, pagesize=A4, rightMargin=2*cm, leftMargin=2*cm, topMargin=2*cm, bottomMargin=2*cm ) styles = getSampleStyleSheet() # Custom styles title_style = ParagraphStyle( 'CustomTitle', parent=styles['Title'], fontSize=20, textColor=colors.HexColor('#1a237e'), spaceAfter=4, spaceBefore=0, alignment=TA_CENTER, fontName='Helvetica-Bold' ) subtitle_style = ParagraphStyle( 'Subtitle', parent=styles['Normal'], fontSize=10, textColor=colors.HexColor('#5c6bc0'), spaceAfter=10, alignment=TA_CENTER, fontName='Helvetica' ) h1_style = ParagraphStyle( 'H1', parent=styles['Heading1'], fontSize=12, textColor=colors.white, spaceBefore=12, spaceAfter=4, fontName='Helvetica-Bold', leftIndent=-0.3*cm, backColor=colors.HexColor('#1a237e'), borderPad=4, ) h2_style = ParagraphStyle( 'H2', parent=styles['Heading2'], fontSize=10.5, textColor=colors.HexColor('#1a237e'), spaceBefore=8, spaceAfter=3, fontName='Helvetica-Bold', ) body_style = ParagraphStyle( 'Body', parent=styles['Normal'], fontSize=9.5, spaceAfter=4, leading=14, fontName='Helvetica', alignment=TA_JUSTIFY ) bullet_style = ParagraphStyle( 'Bullet', parent=styles['Normal'], fontSize=9.5, spaceAfter=3, leading=13, fontName='Helvetica', leftIndent=14, bulletIndent=4, ) note_style = ParagraphStyle( 'Note', parent=styles['Normal'], fontSize=8.5, textColor=colors.HexColor('#555555'), spaceAfter=4, leading=12, fontName='Helvetica-Oblique', alignment=TA_CENTER ) # Table style helper def make_table_style(header_color='#1a237e'): return TableStyle([ ('BACKGROUND', (0,0), (-1,0), colors.HexColor(header_color)), ('TEXTCOLOR', (0,0), (-1,0), colors.white), ('FONTNAME', (0,0), (-1,0), 'Helvetica-Bold'), ('FONTSIZE', (0,0), (-1,0), 9), ('ALIGN', (0,0), (-1,-1), 'LEFT'), ('VALIGN', (0,0), (-1,-1), 'TOP'), ('FONTNAME', (0,1), (-1,-1), 'Helvetica'), ('FONTSIZE', (0,1), (-1,-1), 8.5), ('ROWBACKGROUNDS', (0,1), (-1,-1), [colors.HexColor('#f5f5f5'), colors.white]), ('GRID', (0,0), (-1,-1), 0.4, colors.HexColor('#cccccc')), ('LEFTPADDING', (0,0), (-1,-1), 6), ('RIGHTPADDING', (0,0), (-1,-1), 6), ('TOPPADDING', (0,0), (-1,-1), 4), ('BOTTOMPADDING', (0,0), (-1,-1), 4), ]) story = [] # ── Title Block ────────────────────────────────────────────────────────────── story.append(Paragraph("GENE THERAPY", title_style)) story.append(Paragraph("Short Notes &nbsp;|&nbsp; Theory Exam — 10 Marks", subtitle_style)) story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#1a237e'), spaceAfter=8)) # ── 1. Definition ───────────────────────────────────────────────────────────── story.append(Paragraph("1. DEFINITION", h1_style)) story.append(Paragraph( "Gene therapy is the <b>deliberate introduction of genetic material into human somatic cells for therapeutic, " "prophylactic, or diagnostic purposes</b> (UK Gene Therapy Advisory Committee). " "More broadly, it is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. " "The goal is to correct genetic defects at their most fundamental level — the gene itself. " "In 2012, the first gene therapy product was licensed in the US and Europe (for lipoprotein lipase deficiency).", body_style )) # ── 2. Types ────────────────────────────────────────────────────────────────── story.append(Paragraph("2. TYPES OF GENE THERAPY", h1_style)) types_data = [ ['Type', 'Target Cells', 'Heritable?', 'Current Status'], ['Somatic gene therapy', 'Non-reproductive cells\n(liver, lung, bone marrow)', 'No', 'Permitted; in clinical use'], ['Germline gene therapy', 'Egg / sperm / early embryo', 'Yes — passes to offspring', 'Universally banned (ethically unacceptable)'], ] types_table = Table(types_data, colWidths=[3.8*cm, 5*cm, 3.5*cm, 4.5*cm]) types_table.setStyle(make_table_style()) story.append(types_table) story.append(Spacer(1, 6)) # ── 3. Approaches ──────────────────────────────────────────────────────────── story.append(Paragraph("3. GENE TRANSFER STRATEGIES", h1_style)) story.append(Paragraph("<b>A. Ex vivo (Indirect) Approach</b>", h2_style)) ex_vivo_bullets = [ "Cells removed from patient and cultured in vitro", "Therapeutic gene introduced into cells in culture", "Genetically corrected cells reintroduced into the patient", "<i>Example:</i> ADA-SCID — white blood cells corrected ex vivo and reinfused; bone marrow stem cells corrected ex vivo for beta-thalassemia", ] for b in ex_vivo_bullets: story.append(Paragraph(f"• {b}", bullet_style)) story.append(Paragraph("<b>B. In vivo (Direct) Approach</b>", h2_style)) in_vivo_bullets = [ "Therapeutic gene injected directly into target tissue/organ or bloodstream", "Most direct strategy; can theoretically treat many hereditary disorders", "<i>Example:</i> CFTR gene via nasal spray for cystic fibrosis; AAV vector IV injection for spinal muscular atrophy", ] for b in in_vivo_bullets: story.append(Paragraph(f"• {b}", bullet_style)) # ── 4. Vectors ──────────────────────────────────────────────────────────────── story.append(Paragraph("4. VECTORS USED IN GENE THERAPY", h1_style)) story.append(Paragraph("<b>A. Viral Vectors</b>", h2_style)) vec_data = [ ['Vector', 'Key Properties', 'Advantages', 'Limitations'], ['Retrovirus', 'RNA virus; integrates into host genome; incapable of replication (engineered)', 'Stable, long-term expression;\n~8 kb insert capacity;\nnon-toxic', 'Requires dividing cells;\nrisk of insertional mutagenesis'], ['Lentivirus\n(e.g., HIV-derived)', 'Retrovirus subtype; integrates into non-dividing cells', 'Infects neurons & non-dividing cells;\nno gene locus preference (lower oncogene risk)', 'Complex biosafety requirements'], ['Adeno-associated\nvirus (AAV)', 'Remains episomal; non-integrating; infects dividing and non-dividing cells', 'No strong immune response;\nlong-term expression;\nwidely used clinically', 'Small insert capacity (~5 kb only)'], ['Adenovirus', 'Non-integrating; high titer; wide cell tropism', 'Large inserts (30–35 kb);\ninfects many cell types', 'Strong immune response;\ncaused patient death (OTC trial, 1999);\nnow restricted to cancer therapy'], ] vec_table = Table(vec_data, colWidths=[3*cm, 4.8*cm, 4*cm, 4.5*cm]) vec_table.setStyle(make_table_style()) story.append(vec_table) story.append(Paragraph("<b>B. Non-viral Vectors</b>", h2_style)) nonviral = [ "<b>Liposomes</b> (cationic lipid particles): encapsulate DNA; fuse with cell membrane; lower efficiency than viral vectors", "<b>Nanoparticles</b>: targeted drug-like delivery of nucleic acids", "<b>Naked DNA</b>: direct injection into muscle (uniquely retains and expresses foreign DNA)", "<b>Modified mRNA (modRNA)</b>: uridine replaced by pseudouridine — evades Toll-like receptor recognition and RNase degradation; non-integrating; promising for cardiac therapy", ] for b in nonviral: story.append(Paragraph(f"• {b}", bullet_style)) # ── 5. Requirements ─────────────────────────────────────────────────────────── story.append(Paragraph("5. ESSENTIAL REQUIREMENTS FOR GENE THERAPY", h1_style)) req_data = [ ['Requirement', 'Detail'], ['1. Known molecular defect', 'Identity of the affected gene must be established'], ['2. Functional gene copy', 'A cDNA clone of the gene must be available'], ['3. Appropriate vector', 'Safe, efficient delivery into target tissue'], ['4. Appropriate target cell', 'Long-lived, accessible; able to be re-introduced if cultured ex vivo'], ['5. Regulatory components', 'Correct promoter/enhancer for regulated expression (critical in thalassemia — over-expression harmful)'], ['6. Efficacy & safety evidence', 'Demonstrated in cell culture and animal (ideally large animal) models'], ['7. Regulatory approval', 'Institutional review board + government agency (FDA in US; GTAC in UK)'], ['8. Favourable risk-benefit ratio', 'Substantial disease burden must justify the risks versus alternative therapies'], ] req_table = Table(req_data, colWidths=[5*cm, 11.3*cm]) req_table.setStyle(make_table_style()) story.append(req_table) # ── 6. Diseases ─────────────────────────────────────────────────────────────── story.append(Paragraph("6. DISEASES TREATED / CANDIDATES", h1_style)) story.append(Paragraph("<b>Approved / Successful Clinical Trials:</b>", h2_style)) dis_data = [ ['Disease', 'Defective Gene/Protein', 'Vector', 'Outcome'], ['X-linked SCID', 'IL2RG (γ-cytokine receptor)', 'Retroviral\n(SIN vectors)', '27/32 patients improved; 5 developed treatable leukemia-like disorder'], ['ADA-SCID', 'Adenosine deaminase (ADA)', 'Retroviral', '29/40 patients off enzyme replacement therapy'], ['X-linked adrenoleukodystrophy', 'ABCD1 (peroxisomal ABC transporter)', 'Lentiviral', 'Cerebral demyelination arrested in 17/19 boys'], ['Spinal muscular atrophy', 'SMN1', 'AAV (IV injection)', 'Marked improvement in >1800 patients; FDA approved (Zolgensma)'], ['Hemophilia B', 'Factor IX (F9)', 'AAV (IV injection)', 'Factor IX at 1–7% normal; >20 patients stopped prophylaxis'], ['Leber congenital amaurosis', 'RPE65', 'AAV (retinal injection)', 'FDA approved; ages 12 months–65 years'], ['Beta-thalassemia', 'β-globin mutations', 'Lentiviral', 'Some patients transfusion-independent'], ['LPL deficiency', 'LPL gene', 'AAV (intramuscular)', 'First ever approved gene therapy product (Europe 2012)'], ] dis_table = Table(dis_data, colWidths=[3.8*cm, 3.8*cm, 2.8*cm, 5.9*cm]) dis_table.setStyle(make_table_style()) story.append(dis_table) story.append(Spacer(1, 4)) story.append(Paragraph("<b>Other Candidates:</b> Cystic fibrosis, Parkinson disease, Familial hypercholesterolemia, " "Phenylketonuria, Muscular dystrophy, Sickle cell anemia, HIV/AIDS, Cancers " "(melanoma, brain tumours, lung, ovarian, renal), Cardiovascular disease, Rheumatoid arthritis.", body_style)) # ── 7. Risks ────────────────────────────────────────────────────────────────── story.append(Paragraph("7. RISKS AND LIMITATIONS", h1_style)) risks = [ ("<b>Adverse reaction to vector</b>", "Patient may mount a strong immune/inflammatory response to the vector. " "A patient in an OTC (ornithine transcarbamylase) deficiency trial died in 1999 from a massive immune reaction to the adenoviral vector."), ("<b>Insertional mutagenesis → Malignancy</b>", "Integrated gene may activate a proto-oncogene or disrupt a tumour suppressor gene. " "In X-linked SCID trials, retroviral vector inserted into the LMO-2 oncogene (chromosome 11), causing leukemia in 3–5 patients (one fatal)."), ("<b>Insertional inactivation of an essential gene</b>", "Random integration may disrupt a housekeeping gene (rare but possible). " "Current SIN (self-inactivating) vectors have been engineered to minimise this risk."), ("<b>Short-lived expression</b>", "Cell turnover and gene silencing may reduce efficacy over time; repeat dosing difficult due to immune memory."), ("<b>Delivery challenges</b>", "Targeting specific cell types in vivo; small insert size of AAV (~5 kb); CNS delivery requires invasive procedures."), ("<b>Extremely high cost</b>", "Zolgensma (SMA) costs ~$2–3 million per dose; Gaucher disease therapy >$150,000/year; limits global access."), ] for title, detail in risks: story.append(Paragraph(f"• {title}: {detail}", bullet_style)) # ── 8. Ethics & Regulation ──────────────────────────────────────────────────── story.append(Paragraph("8. ETHICAL AND REGULATORY ASPECTS", h1_style)) ethics = [ "<b>Somatic gene therapy</b>: Ethically acceptable; targets the individual only; does not affect offspring", "<b>Germline gene therapy</b>: Universally banned; heritable changes raise concerns about consent of future generations and eugenics; no country permits it", "<b>Enhancement vs. therapy debate</b>: Use for height, intelligence, or athletic ability is ethically prohibited", "<b>Equal access</b>: Ultra-expensive therapies raise justice concerns", "<b>Regulatory bodies</b>: FDA + Recombinant DNA Advisory Committee (USA); GTAC (UK); Institutional Review Boards worldwide", ] for b in ethics: story.append(Paragraph(f"• {b}", bullet_style)) # ── 9. Recent Advances ──────────────────────────────────────────────────────── story.append(Paragraph("9. RECENT ADVANCES", h1_style)) advances = [ "<b>CRISPR-Cas9 gene editing</b>: Corrects the mutation in its native genomic context; more precise than gene addition; reduces insertional mutagenesis risk", "<b>iPSC-based therapy</b>: Patient somatic cells reprogrammed to iPSCs → gene corrected → differentiated → transplanted back; avoids immune rejection", "<b>modRNA therapy</b>: Modified mRNA (pseudouridine substitution) resists immune recognition and RNase; non-integrating; promising for cardiac regeneration", "<b>CAR-T cell therapy</b>: T cells genetically engineered ex vivo to express chimeric antigen receptors targeting cancer cells (e.g., haematological malignancies)", "<b>siRNA/RNAi</b>: Used to silence dominant mutant alleles (e.g., osteogenesis imperfecta); vectors carrying siRNAs selectively degrade mutant mRNA", ] for b in advances: story.append(Paragraph(f"• {b}", bullet_style)) # ── 10. Summary Table ───────────────────────────────────────────────────────── story.append(Paragraph("10. QUICK SUMMARY", h1_style)) summary_data = [ ['Feature', 'Key Point'], ['Definition', 'Introduction of genetic material into somatic cells for therapeutic purposes'], ['Types', 'Somatic (permitted) vs Germline (universally banned)'], ['Approaches', 'Ex vivo (cells removed, corrected, reinfused) vs In vivo (direct injection)'], ['Main viral vectors', 'Retrovirus, Lentivirus, AAV, Adenovirus'], ['Non-viral vectors', 'Liposomes, nanoparticles, naked DNA, modRNA'], ['First approval', 'Alipogene tiparvovec (LPL deficiency) — Europe, 2012'], ['Key FDA-approved therapies', 'Zolgensma (SMA), Luxturna (Leber amaurosis), Hemgenix (Hemophilia B)'], ['Main risks', 'Immune reaction, insertional mutagenesis, malignancy, short-lived expression'], ['Germline therapy', 'Ethically unacceptable; universally banned worldwide'], ['Future directions', 'CRISPR, iPSC therapy, modRNA, CAR-T cells'], ] summary_table = Table(summary_data, colWidths=[5*cm, 11.3*cm]) summary_table.setStyle(make_table_style()) story.append(summary_table) # ── Footer reference ────────────────────────────────────────────────────────── story.append(Spacer(1, 10)) story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor('#9e9e9e'), spaceAfter=4)) story.append(Paragraph( "<i>Sources: Thompson &amp; Thompson Genetics and Genomics in Medicine (9th ed.) • " "Emery's Elements of Medical Genetics and Genomics • " "Schwartz's Principles of Surgery (11th ed.)</i>", note_style )) doc.build(story) print("PDF created successfully:", output_path) EOF

python3 << 'EOF' from reportlab.lib.pagesizes import A4 from reportlab.lib.styles import getSampleStyleSheet, ParagraphStyle from reportlab.lib.units import cm from reportlab.lib import colors from reportlab.platypus import (SimpleDocTemplate, Paragraph, Spacer, Table, TableStyle, HRFlowable, KeepTogether) from reportlab.lib.enums import TA_CENTER, TA_LEFT, TA_JUSTIFY output_path = "/tmp/workspace/gene-therapy/HIPEC_Short_Notes.pdf" doc = SimpleDocTemplate( output_path, pagesize=A4, rightMargin=2*cm, leftMargin=2*cm, topMargin=2*cm, bottomMargin=2*cm ) styles = getSampleStyleSheet() title_style = ParagraphStyle('T', parent=styles['Title'], fontSize=20, textColor=colors.HexColor('#b71c1c'), spaceAfter=4, alignment=TA_CENTER, fontName='Helvetica-Bold') subtitle_style = ParagraphStyle('ST', parent=styles['Normal'], fontSize=10, textColor=colors.HexColor('#c62828'), spaceAfter=10, alignment=TA_CENTER, fontName='Helvetica') h1_style = ParagraphStyle('H1', parent=styles['Normal'], fontSize=11.5, textColor=colors.white, spaceBefore=12, spaceAfter=5, fontName='Helvetica-Bold', backColor=colors.HexColor('#b71c1c'), borderPad=5, leftIndent=-0.3*cm) h2_style = ParagraphStyle('H2', parent=styles['Normal'], fontSize=10.5, textColor=colors.HexColor('#b71c1c'), spaceBefore=8, spaceAfter=3, fontName='Helvetica-Bold') body_style = ParagraphStyle('B', parent=styles['Normal'], fontSize=9.5, spaceAfter=4, leading=14, fontName='Helvetica', alignment=TA_JUSTIFY) bullet_style = ParagraphStyle('BL', parent=styles['Normal'], fontSize=9.5, spaceAfter=3, leading=13, fontName='Helvetica', leftIndent=14, bulletIndent=4) note_style = ParagraphStyle('N', parent=styles['Normal'], fontSize=8.5, textColor=colors.HexColor('#555555'), spaceAfter=4, leading=12, fontName='Helvetica-Oblique', alignment=TA_CENTER) def tbl(data, colWidths, hdr='#b71c1c'): t = Table(data, colWidths=colWidths) t.setStyle(TableStyle([ ('BACKGROUND',(0,0),(-1,0),colors.HexColor(hdr)), ('TEXTCOLOR',(0,0),(-1,0),colors.white), ('FONTNAME',(0,0),(-1,0),'Helvetica-Bold'), ('FONTSIZE',(0,0),(-1,0),9), ('ALIGN',(0,0),(-1,-1),'LEFT'), ('VALIGN',(0,0),(-1,-1),'TOP'), ('FONTNAME',(0,1),(-1,-1),'Helvetica'), ('FONTSIZE',(0,1),(-1,-1),8.5), ('ROWBACKGROUNDS',(0,1),(-1,-1),[colors.HexColor('#fce4e4'),colors.white]), ('GRID',(0,0),(-1,-1),0.4,colors.HexColor('#cccccc')), ('LEFTPADDING',(0,0),(-1,-1),6), ('RIGHTPADDING',(0,0),(-1,-1),6), ('TOPPADDING',(0,0),(-1,-1),4), ('BOTTOMPADDING',(0,0),(-1,-1),4), ])) return t story = [] # Title story.append(Paragraph("HIPEC", title_style)) story.append(Paragraph("Hyperthermic Intraperitoneal Chemotherapy &nbsp;|&nbsp; Short Notes — Theory Exam", subtitle_style)) story.append(HRFlowable(width="100%", thickness=2, color=colors.HexColor('#b71c1c'), spaceAfter=8)) # 1. Definition story.append(Paragraph("1. DEFINITION", h1_style)) story.append(Paragraph( "<b>HIPEC (Hyperthermic Intraperitoneal Chemotherapy)</b> is the intraoperative administration of heated " "chemotherapy directly into the peritoneal cavity, performed immediately after <b>Cytoreductive Surgery (CRS)</b>. " "It is a multimodal locoregional treatment strategy for peritoneal surface malignancies (PSM). " "The combined procedure is referred to as <b>CRS + HIPEC</b> and represents the gold standard for selected " "patients with peritoneal carcinomatosis.", body_style)) # 2. Rationale / Mechanism story.append(Paragraph("2. RATIONALE AND MECHANISM OF ACTION", h1_style)) story.append(Paragraph("<b>Why intraperitoneal (IP) chemotherapy?</b>", h2_style)) for b in [ "Achieves <b>higher local drug concentrations</b> directly at peritoneal tumor deposits than systemic IV chemotherapy", "<b>Reduced systemic toxicity</b> — peritoneal-plasma barrier limits systemic absorption", "Peritoneal carcinomatosis is predominantly a <b>locoregional disease</b>; systemic chemo alone poorly penetrates the peritoneum", ]: story.append(Paragraph(f"• {b}", bullet_style)) story.append(Paragraph("<b>Why hyperthermia (40–43°C)?</b>", h2_style)) for b in [ "<b>Direct cytotoxicity</b>: heat itself damages and kills tumor cells (tumour cells more sensitive to heat than normal cells)", "<b>Potentiates chemotherapy</b>: hyperthermia increases drug uptake, enhances DNA damage, impairs tumour DNA repair mechanisms", "<b>Increased tissue penetration</b>: heat increases vascular permeability allowing deeper drug penetration into tumour nodules", "Synergistic with platinum agents (cisplatin, oxaliplatin) and mitomycin-C", ]: story.append(Paragraph(f"• {b}", bullet_style)) # 3. Techniques story.append(Paragraph("3. TECHNIQUE OF HIPEC ADMINISTRATION", h1_style)) story.append(Paragraph( "HIPEC requires a <b>heating perfusion apparatus</b> that homogenously delivers heated chemotherapy solution " "through inflow/outflow cannulas with temperature probes.", body_style)) tech_data = [ ['Technique', 'Description', 'Advantages', 'Disadvantages'], ['Open\n(Coliseum technique)', 'Abdomen left open; surgeon manually agitates the heated chemotherapy to distribute it', 'Better distribution; direct visualization', 'Heat/chemical exposure risk to OR staff; heat loss'], ['Closed technique\n(more common)', 'Inflow/outflow cannulas placed; abdomen closed before chemotherapy infused; warmed to ~40°C then circulated for 30–90 min', 'Safer for OR staff; maintains hyperthermic temperature better', 'Less uniform distribution'], ['Laparoscopic HIPEC', 'Minimally invasive approach; complete laparoscopic peritonectomy described', 'Less morbidity; same oncologic outcomes in selected patients', 'Highly specialized; limited indications'], ] story.append(tbl(tech_data, [3.2*cm, 5*cm, 3.5*cm, 4.6*cm])) story.append(Spacer(1,4)) story.append(Paragraph( "<b>Temperature:</b> Abdomen warmed to 40°C; chemotherapy circulated at 40–43°C for <b>60–90 minutes</b> (varies by drug). " "At completion, chemotherapy solution is drained from the abdomen before closure.", body_style)) # 4. Drugs story.append(Paragraph("4. CHEMOTHERAPEUTIC AGENTS USED IN HIPEC", h1_style)) story.append(Paragraph( "Different drugs are used depending on the primary tumour histology. " "The most common agents are <b>Cisplatin, Mitomycin-C, Doxorubicin, and Oxaliplatin</b>.", body_style)) drug_data = [ ['Indication', 'First-line HIPEC Drug(s)', 'Notes'], ['Ovarian cancer', 'Cisplatin', 'CRS + HIPEC standard for interval cytoreduction'], ['Colorectal cancer', 'Mitomycin-C / Oxaliplatin', 'Mitomycin-C recommended by ASPSM; 60–90 min perfusion'], ['Pseudomyxoma peritonei', 'Mitomycin-C / Oxaliplatin', 'Gold standard regardless of PCI in resectable disease'], ['Peritoneal mesothelioma', 'Cisplatin / Mitomycin-C', 'Gold standard in resectable disease'], ['Gastric cancer', 'Mitomycin-C / Oxaliplatin / Cisplatin', 'PCI ≤7 may benefit'], ['Appendiceal cancer', 'Mitomycin-C / Oxaliplatin', 'CRS + HIPEC regardless of PCI if resectable'], ] story.append(tbl(drug_data, [4*cm, 4.5*cm, 7.8*cm])) story.append(Spacer(1,4)) story.append(Paragraph( "<i>Less commonly used: Paclitaxel, Gemcitabine, Melphalan.</i>", note_style)) # 5. CRS story.append(Paragraph("5. CYTOREDUCTIVE SURGERY (CRS)", h1_style)) story.append(Paragraph( "CRS is the surgical component performed <b>before</b> HIPEC. It aims to remove all visible tumour from the peritoneal cavity. " "<b>Completeness of cytoreduction (CC score)</b> is the most important prognostic factor.", body_style)) for b in [ "<b>Omentectomy</b>", "<b>Peritonectomy</b>: stripping of involved parietal and visceral peritoneum", "<b>Organ resection</b>: resection of any involved organs (spleen, bowel, gallbladder, uterus, ovaries, etc.)", "<b>Appendectomy</b> if appendix is still present", "No residual tumour nodules greater than <b>2 mm in diameter</b> should remain (macroscopic clearance)", ]: story.append(Paragraph(f"• {b}", bullet_style)) story.append(Paragraph("<b>CC (Completeness of Cytoreduction) Score:</b>", h2_style)) cc_data = [ ['CC Score', 'Residual Tumour', 'HIPEC?'], ['CC-0', 'No visible residual tumour', 'Ideal — HIPEC given'], ['CC-1', 'Nodules <2.5 mm (treated by HIPEC)', 'Acceptable; HIPEC given'], ['CC-2', 'Nodules 2.5 mm – 2.5 cm', 'Not ideal — HIPEC withheld'], ['CC-3', 'Nodules >2.5 cm', 'Incomplete — HIPEC not indicated'], ] story.append(tbl(cc_data, [2.5*cm, 7*cm, 6.8*cm])) # 6. PCI story.append(Paragraph("6. PERITONEAL CANCER INDEX (PCI)", h1_style)) story.append(Paragraph( "The PCI is the scoring system used to <b>quantify the extent of peritoneal disease</b> and guide patient selection for CRS+HIPEC. " "The abdomen and pelvis are divided into <b>13 regions</b>; each region is scored 0–3 based on the size of the largest tumour nodule. " "<b>Maximum PCI = 39.</b>", body_style)) pci_data = [ ['Lesion Size (LS) Score', 'Tumour Size', 'PCI Total', 'Recommendation'], ['LS-0', 'No tumour nodules', '≤10', 'Resection recommended (best outcomes)'], ['LS-1', 'Nodules <0.5 cm', '11–20', 'Resection may be considered'], ['LS-2', 'Nodules 0.5–5.0 cm', '>20', 'Resection generally not recommended'], ['LS-3', 'Nodules >5.0 cm', '—', '—'], ] story.append(tbl(pci_data, [3.5*cm, 3.5*cm, 3*cm, 6.3*cm])) story.append(Spacer(1,4)) story.append(Paragraph( "<b>Prognostic significance (colorectal cancer):</b> PCI ≤10 → ~50% 5-year survival; " "PCI 11–20 → ~20% 5-year survival; PCI >20 → near 0% 5-year survival.", body_style)) # 7. Indications story.append(Paragraph("7. INDICATIONS FOR CRS + HIPEC", h1_style)) ind_data = [ ['Tumour Type', 'Indication / Notes'], ['Pseudomyxoma peritonei (PMP)', 'Gold standard; CRS + HIPEC regardless of PCI in resectable disease'], ['Peritoneal mesothelioma', 'Gold standard; CRS + HIPEC in resectable disease'], ['Colorectal cancer with peritoneal metastasis', 'PCI ≤20; complete CRS achievable; combine with systemic chemo'], ['Ovarian cancer', 'Interval CRS + HIPEC (cisplatin) with perioperative systemic chemo; CRS ± HIPEC in upfront surgery'], ['Appendiceal cancer (LAMN, adenocarcinoma)', 'CRS + HIPEC if complete cytoreduction achievable'], ['Gastric cancer with peritoneal metastasis', 'PCI ≤7; limited, selected patients in combination with gastrectomy'], ['Rare primary tumours (pancreas, cholangiocarcinoma)', 'CRS + HIPEC with perioperative SC for limited chemosensitive disease'], ] story.append(tbl(ind_data, [5.5*cm, 10.8*cm])) # 8. Contraindications story.append(Paragraph("8. CONTRAINDICATIONS", h1_style)) story.append(Paragraph("<b>Absolute Contraindications:</b>", h2_style)) for b in [ "Incomplete CRS (CC-2 or CC-3; CC-1 acceptable only for PMP)", "PCI above the disease-specific threshold", "Unresectable extraperitoneal (systemic) disease", "Severe malnutrition", "Serious renal disease", "Aggravation/progression on systemic chemotherapy", ]: story.append(Paragraph(f"• {b}", bullet_style)) story.append(Paragraph("<b>Relative Contraindications:</b>", h2_style)) for b in [ "WHO Performance Status >2", "Creatinine clearance <60 mL/min", "<i>Note: Age alone is NO longer a contraindication</i>", ]: story.append(Paragraph(f"• {b}", bullet_style)) # 9. Pre-operative workup story.append(Paragraph("9. PRE-OPERATIVE EVALUATION", h1_style)) eval_data = [ ['Goal', 'Investigation'], ['Confirm diagnosis', 'CT scan, biopsy'], ['Quantify tumour burden (PCI)', 'Diagnostic laparoscopy (most accurate), CT, MRI'], ['Detect extraperitoneal disease', 'PET-CT, CT chest/abdomen/pelvis'], ['Assess surgical resectability', 'Diagnostic laparoscopy, CT/MRI, exploratory laparotomy'], ['Tumour markers (for follow-up)', 'CEA, CA19-9, CA-125'], ] story.append(tbl(eval_data, [5.5*cm, 10.8*cm])) story.append(Spacer(1,4)) story.append(Paragraph( "<b>Imaging notes:</b> CT has low sensitivity but high specificity; detects only 11–28% of implants <0.5 cm. " "MRI has higher sensitivity and accuracy. PET-CT has low value for mucinous tumours. " "Diagnostic laparoscopy is the most accurate but may still miss small bowel/porta hepatis involvement.", body_style)) # 10. Outcomes story.append(Paragraph("10. OUTCOMES AND KEY CLINICAL TRIALS", h1_style)) trial_data = [ ['Trial', 'Population', 'Key Finding'], ['Verwaal et al. (Netherlands RCT, 2003)', '105 pts: colorectal peritoneal metastasis', 'CRS + HIPEC: 22.3 months median OS vs 12.6 months with 5-FU/leucovorin alone; significant improvement'], ['PRODIGE 7 (France RCT, 2021)\nLancet Oncol', '265 pts: CRS+HIPEC vs CRS alone (colorectal); HIPEC = oxaliplatin 30 min', 'No difference in OS (41.7 vs 41.2 months); CRS alone established as standard of care; PCI 11–15 subgroup benefited from HIPEC (HR 0.44)'], ['COLOPEC (Dutch RCT)', '204 pts: adjuvant HIPEC + chemo vs chemo alone (T4/perforated CRC)', 'No difference in metastasis-free survival at 18 months; slight increase in complications with HIPEC'], ['Spiliotis (RCT, 2015)', 'Recurrent ovarian cancer: CRS+HIPEC vs CRS alone', 'HIPEC + CRS: 13-month improvement in survival vs CRS alone'], ['General outcomes (colorectal)', 'After complete CRS + HIPEC', '5-year survival 30–40%; median OS ~36 months after complete cytoreduction'], ['Pseudomyxoma/mesothelioma', 'After CRS + HIPEC', 'Best outcomes: PMP 5-year survival 70–80%; mesothelioma median OS 5+ years in selected patients'], ] story.append(tbl(trial_data, [4*cm, 4.8*cm, 7.5*cm])) # 11. Morbidity/Mortality story.append(Paragraph("11. MORBIDITY, MORTALITY AND COMPLICATIONS", h1_style)) for b in [ "<b>Operative mortality:</b> Currently 1–3% at experienced centres (was 8% in early trials)", "<b>Major morbidity:</b> 20–40%; includes anastomotic leak, wound infection, bowel obstruction, haematological toxicity", "<b>Haematological toxicity:</b> Myelosuppression (cisplatin, mitomycin-C); neutropaenia", "<b>Renal toxicity:</b> Cisplatin-related nephrotoxicity", "<b>Neuropathy:</b> Oxaliplatin-related peripheral neuropathy", "<b>Prolonged hospital stay:</b> Mean 14–21 days", "<b>ERAS protocols</b> (Enhanced Recovery After Surgery) reduce complications and length of stay; now standard post-operative care for CRS ± HIPEC", ]: story.append(Paragraph(f"• {b}", bullet_style)) # 12. Summary story.append(Paragraph("12. QUICK SUMMARY", h1_style)) sum_data = [ ['Feature', 'Key Point'], ['Full name', 'Hyperthermic Intraperitoneal Chemotherapy'], ['Temperature', '40–43°C; circulated for 60–90 minutes'], ['Combined with', 'Cytoreductive Surgery (CRS) always'], ['Main drugs', 'Cisplatin (ovarian), Mitomycin-C (colorectal/PMP), Oxaliplatin'], ['Techniques', 'Open (Coliseum) or Closed (more common); laparoscopic in selected cases'], ['Disease staging', 'Peritoneal Cancer Index (PCI): 13 regions, 0–39 scale'], ['Best candidates', 'Complete cytoreduction achievable (CC-0/CC-1); PCI ≤20'], ['Gold standard for', 'Pseudomyxoma peritonei, peritoneal mesothelioma'], ['Proven benefit in', 'Ovarian (interval CRS), selected colorectal peritoneal metastasis'], ['Key trial', 'PRODIGE 7 (2021): CRS alone adequate; HIPEC benefit in PCI 11–15 subgroup'], ['Main risks', 'Haematological toxicity, renal toxicity, anastomotic leak, prolonged stay'], ['Contraindications', 'Incomplete CRS, PCI too high, extraperitoneal disease, severe malnutrition'], ['Post-op care', 'ERAS protocol recommended'], ['Newer alternative', 'PIPAC (Pressurized Intraperitoneal Aerosol Chemo) for unresectable/recurrent disease'], ] story.append(tbl(sum_data, [4.5*cm, 11.8*cm])) # Footer story.append(Spacer(1,10)) story.append(HRFlowable(width="100%", thickness=0.5, color=colors.HexColor('#9e9e9e'), spaceAfter=4)) story.append(Paragraph( "<i>Sources: Fischer's Mastery of Surgery 8th ed. • Sabiston Textbook of Surgery • " "Yamada's Textbook of Gastroenterology 7th ed. • Current Surgical Therapy 14th ed. • " "Mulholland and Greenfield's Surgery 7th ed.</i>", note_style)) doc.build(story) print("PDF created:", output_path) EOF